Post-Injury Administration of Recombinant TRIM72 Protein Ameliorates Bleomycin-Induced Pulmonary Fibrosis

Autor:	X. Zhao, Nagaraja N. Nagre, Xiaofei Cong
Rok vydání:	2020
Předmět:	chemistry.chemical_compound chemistry business.industry law Pulmonary fibrosis medicine Recombinant DNA Pharmacology medicine.disease business Bleomycin Post injury law.invention
Zdroj:	B64. MECHANISTIC ADVANCES IN LUNG FIBROSIS.
DOI:	10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4044
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::81327c72d6ce963ce56e32a8f540c33b https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4044 Zobrazit plný text záznamu